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Symptoms of Parkinson’s can result in low physical activity and poor sleep patterns which can have a detrimental eﬀect on a person’s
quality of life. To date, studies looking into exercise interventions for people with Parkinson’s (PwP) for symptom management are
promising but inconclusive.+e aim of this study is to estimate the eﬀect of a clearly deﬁned exercise prescription on general physical
activity levels, fatigue, sleep, and quality of life in PwP. Method. PwP randomised into either an exercise group (29; 16 males, 13
females; mean age 67 years (7.12)) or a control handwriting group (36; 19 males; 17 females; mean age 67 years (5.88)) as part of
a larger trial were included in this substudy if they had completed a 6-monthweekly exercise programme (intervention group) and had
complete objective physical activity data (intervention and control group). Sleep and fatigue were recorded from self-reported
measures, and physical activity levels measured through the use of accelerometers worn 24 hours/day over a seven-day testing period
at baseline and following the 24-week intervention. A Wilcoxon’s test followed by a Mann–Whitney post hoc analysis was used, and
eﬀect sizes were calculated. Results. Participants showed a signiﬁcant increase in time spent in sedentary and light activities during the
overnight period postintervention in both exercise and handwriting groups (p< 0.05) with a moderate eﬀect found for the change in
sedentary and light activities in the overnight hours for both groups, over time (0.32 and 0.37-0.38, resp.).+ere was no impact on self-
reported fatigue or sleep. Conclusion. +e observed moderate eﬀect on sedentary and light activities overnight could suggest an
objective improvement in sleep patterns for individuals participating in both exercise and handwriting interventions.+is supports the
need for further studies to investigate the role of behavioural interventions for nonmotor symptoms.
1. Introduction
Parkinson’s is a progressive neurological condition, and it
is estimated that one in every 350 people in the UK are
diagnosed with the condition. Although pharmaceutical
interventions are the primary treatment option, exercise
is becoming increasingly recognised as an eﬀective addi-
tion to commonly used drug treatments for the control of
both motor and nonmotor symptoms [1]. +ere is strong
evidence supporting beneﬁcial eﬀects of exercise programs
on disease progression, motor and nonmotor symptom
management, and health and wellbeing in PwP [2–8].
Exercise interventions and a dose of 30 minutes or more
a week of moderate to vigorous physical activity have been
suggested to positively impact on the global nonmotor
symptom burden including depression, apathy, fatigue,
daytime sleepiness, sleep, and cognition [2–7, 9]. However,
the evidence supporting a positive beneﬁt of exercise to
physical activity, fatigue, daytime sleepiness, and sleep is
not strong [9].
PwP report sleep problems, daytime sleepiness, and fa-
tigue as signiﬁcant nonmotor symptoms [10–12]. When
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considering the mechanism of potential eﬀects of exercise on
these symptoms, there are a number of possible positive in-
teractions of a physically active lifestyle including its impact to
provide cognitive stimulation, meaningful social interactions,
and improvement in healthy eating which may induce better
sleep and reduce fatigue [13]. +e interaction is complex and
not well understood, with these factors interacting together in
a formative and reﬂective manner [9, 13–16]. It is interesting
that PwP are observed to have reduced motor symptoms in
the morning following sleep, referred to as “sleep beneﬁt” and
that fatigue levels are lower in the morning after sleep [17].
Importantly, sleep-related symptoms in Parkinson’s have been
shown to relate to disease disability and worsening of motor
symptoms [18]. In the general population, exercise is known to
improve sleep and resulting fatigue [19].
+erefore, there is a beneﬁt of understanding the sleep,
exercise, fatigue interaction, and the limited evidence to date
to support the impact of exercise on physical activity, fatigue,
and sleep in PwP [20–23] and the underpinning mechanism.
+is study set out to estimate the potential eﬀect of an exercise
programme that combined aerobic and strength exercises on
sleep patterns, activity levels, and fatigue in a group of PwP
who had adhered to a prescribed aerobic and strength training
exercise program and had at least three out of seven days of
objective activity data collected pre- and postintervention.
+erefore, the aim of this study is to estimate the potential
eﬀect of a clearly deﬁned exercise prescription compared to
an active control condition of a handwriting intervention
matched for social contact on objective measures of physical
activity levels and self-reported measures of fatigue, quality of
life, and sleep in PwP.
2. Methods
2.1.Design. +is research was carried out on a subset of data
collected as part of an interventional study of exercise
training in PwP in which data for PwP were obtained from
a two-arm parallel single-blind phase II randomised con-
trolled trial (RCT) of community-delivered exercise for PwP
[8].+e current study included all participants from the RCT
who were randomised, who adhered to the exercise group in
the RCT (≥ one session a week), and who provided com-
prehensive objective physical activity data in the exercise
group and in the handwriting group. +e trial was registered
with ClinicalTrials.Gov (NCT01439022).
2.2. Setting. Parkinson’s assessments were carried out at the
Movement Science Laboratory, Oxford Brookes University,
Oxford, UK, the intervention took place at community
leisure facilities throughout Oxfordshire and Berkshire, and
the handwriting sessions took place in the home of the
participants.
2.3.Participants. +e study received National Health Service
ethical approval (NRES Committee South Central–
Southampton A: 11/SC/0267) and was conducted in ac-
cordance with the declaration of Helsinki.
People with idiopathic Parkinson’s were recruited from
neurology clinics and GP practices in the +ames Valley,
UK, and through local Parkinson’s UK group meetings.
Inclusion criteria for PwP were as follows: (i) diagnosis of
idiopathic Parkinson’s (as deﬁned by the UK Parkinson’s
Disease Society Brain Bank clinical diagnostic criteria [24])
and (ii) ability to walk ≥100 meters. Exclusion criteria were
as follows: (i) dementia; (ii) history of additional prior
neurological condition; (iii) severe depression or psychosis
or a mental state that would preclude consistent active in-
volvement with the study over its duration; (iv) cardiac
precautions that would prevent the subject from partici-
pating in the intervention; (v) any known contraindication
to exercise; (vi) reduced cognitive function of any cause
(Mini-Mental State Examination <23); and (vii) an ortho-
paedic condition that limited independent walking. Par-
ticipants’ medication was continued as normal and was
recorded.
2.4. Intervention. +e intervention for PwP was a prescribed
exercise program consisting of sessions lasting 60 minutes or
a handwriting control intervention, twice a week over
a period of six months; a detailed description can be found
elsewhere [8]. Demographics were recorded before and after
the intervention and included fatigue using the Fatigue
Severity Scale (FSS) [25] and quality of life using the EQ5D-
5L [26]. Selected questions from the Uniﬁed Parkinson’s
Disease Rating Scale, Parts 1 and 2 subsections were
recorded including the following: (1) Over the past week,
have you had trouble going to sleep at night or staying asleep
through the night? Consider how rested you felt after waking
up in the morning; (2) Over the past week, have you had
trouble staying awake during the daytime? (3) Over the past
week, do you usually have trouble turning over in bed? Only
PwP who adhered (did not discontinue intervention) to the
exercise program and had at least three full days of objective
activity data out of total seven days for both the pre- and
postassessment were included in the training response
analysis. Physical activity in PwP was measured using the
wrist-worn activity monitor (GENEActiv, UK). +e activity
monitor was worn around the wrist for seven consecutive
days following an assessment.+e activity monitor consisted
out of a triaxial accelerometer, sampling at 100Hz for the
duration of seven days. +e data were downloaded from the
device onto a computer and exported as a 60-second epoch
comma delimited ﬁle. A bespoke Excel macro using adjusted
activity cutoﬀ levels derived minutes per day and relevant
percentages spent sedentary, performing light, moderate, or
vigorous activities [27]. +e physical activity data was
analysed in three ways: one 24-hour period, two 12-hour
periods involving a daytime section from 08.00 to 20.00, and
an overnight section from 20.00 to 08.00, and an 8-hour and
a 4-hour evening section from 24.00 to 08.00 and 20.00 to
24.00, respectively. Matthews et al. [28] observed that
a minimum of three days was required to accurately cal-
culate average physical activity levels; therefore, ﬁles with
less than three days of recorded data were excluded from
analysis.
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2.5. Data Analysis. Descriptive statistics were calculated for
demographic characteristics. For activity data, the thresh-
olds were based on amplitude of the single vector magnitude
as assessed by the triaxial accelerometer within the periods
outlined above. Data was presented as median physical
activity levels over a 24-hour period. Due to nonnormality,
for outcome data, a Wilcoxon’s test followed by a Mann–
Whitney post hoc test was used to determine the changes
over time and according to two intervention regimes (ex-
ercise and handwriting). Further and based on the diﬀer-
ences, eﬀect sizes (r�Z/√N) were calculated.
3. Results
3.1. Participants. Participant ﬂow for the PwP recruited to
the RCT can be found elsewhere [8]. Between December
2011 and August 2013 105 participants were recruited, 37
people adhered to the exercise intervention, and acceler-
ometer data were complete on 29 of these participants (16
males, 13 females; mean age 67 years (7.12)) and 36 in the
control handwriting group (19 males; 17 females; mean age
67 years (5.88)) and therefore were included in this sec-
ondary analysis. Demographic information is provided in
supplementary (available here). Changes in health measures
can be seen in Table 1. +ere were no signiﬁcant diﬀerences
pre- and postintervention (p> 0.05) or between groups at
each time point.
3.2. Accelerometer. +e majority of subjects wore the ac-
celerometer for the entire seven days of each of the testing
period, and although a small minority of subjects did not
achieve this target, inclusion criteria for at least three days
out of each seven day period were met. Tables 2–4 show
physical activity measurement results. During 20:00–08:00
hours, sedentary time increased while light activity de-
creased in both groups with the addition of moderate activity
decreasing in the control group (p< 0.05; Table 3). When the
overnight period was considered, from 20:00 to 24:00 and 24:
00 to 08:00, again sedentary time increased in both groups
with a resulting reduction in time spent in light activity in
the intervention group (p< 0.05; Table 4). Eﬀect sizes for the
same time points showed a moderate eﬀect in the in-
tervention and control groups (0.32 and 0.37-0.38, resp.).
4. Discussion
+ese ﬁndings support the potential use of combined aerobic
and strength exercise as a moderator of general physical
activity for PwP and as a potential aid for improving sleep as
evidenced by reduced activity during the nighttime hours.
Importantly, there was a similar eﬀect in the active control
group suggesting that behavioural exercise interventions
may beneﬁt sleep in PwP.
To examine how participants’ physical activity levels
changed over the course of the intervention in greater depth,
the physical activity data were broken down into 12-hour, 8-
hour, and 4-hour time slots. No signiﬁcant diﬀerences were
observed at any physical activity level during daytime;
however, during the overnight period, there was a signiﬁcant
increase in time spent in sedentary and a signiﬁcant decrease
in time spent in light activity observed in both groups. +e
increase in sedentary activity overnight might suggest an
improvement in the participants’ sleep quality, and a good
quality of sleep in PwP has been linked to a greater control
over motor symptoms the following morning [17]. van Gilst
et al. [17] suggest that the beneﬁcial eﬀect of sleep on motor
symptoms in Parkinson’s is due to improved dopaminergic
function during sleep, which increases dopamine levels in
the brain, a phenomenon known as “sleep beneﬁt.”
Symptoms found in Parkinson’s, such as tremors and ri-
gidity can make the initiation and maintenance of sleep
more diﬃcult than in people without the condition, and
therefore any methods or techniques to help improve sleep
quality in PwP would be of use [29]. +e concept of sub-
jective sleep beneﬁt in the absence of actual objective sleep
beneﬁt may also be of clinical relevance to PwP and has been
associated with nonmotor improvements [30]. Between
24.00 and 08.00, sedentary activity increased whilst time
spent in light activity decreased. Participants spent signiﬁ-
cantly more time sedentary following both interventions
between 20.00 and 24.00 whilst signiﬁcantly less time was
also observed at the light activity level during this time
period. +is could suggest that PwP who took part in the
Table 1: Measures of health before and after the 24-week exercise
intervention.
Exercise Handwriting
Before After Before After
FSS 3± 1.38 3± 1.35 4± 1.46 3± 1.56
EQ5D-5L 79.21±12.22 78.48±17.89 76.58±16.29 74.75±17.94
Sleep problemsa 1.5± 1.43 1.3± 1.26 1.4± 1.33 1.5± 1.38
Daytime
sleepinessa 1.5± 0.78 1.5± 0.87 1.2± 0.94 1.3± 0.91
Turning in beda 0.5± 0.69 0.7± 0.65 0.7± 0.62 0.8± 0.84
Values are means± standard deviations. A Wilcoxon signed rank test was
used to determine diﬀerences between pre- and postintervention followed
by a Mann–Whitney test for between-group diﬀerences, with ∗p< 0.05 and∗∗p> 0.05, respectively. FSS: fatigue severity scale; afrom UPDRS, Uniﬁed
Parkinson’s Disease Rating Scale Parts 1 and 2 subscores.
TABLE 2: Objective physical activity levels of participants following
a 24-week exercise intervention averaged over a 24-hour period.
Exercise Handwriting
Before After Z ES Before After Z ES
SED 0.70 0.75 −0.832 0.11 0.68 0.73∗ 3.488 0.41
LIGHT 0.26 0.23 −0.789 0.10 0.28 0.24∗ −3.126 0.37
MOD 0.04 0.03 −0.335 0.04 0.03 0.03∗ −2.388 0.28
VIG 0 0 −0.355 0.05 0 0∗ −2.293 0.27
+e exercise intervention consisted of both aerobic and anaerobic exercise
training for 60 minutes, twice a week for 24 weeks. Values are medians of
fraction of time spent at each level of activity using an accelerometer. A
Wilcoxon signed rank test was used to determine diﬀerences between pre-
and postintervention followed by a Mann–Whitney test for between-group
diﬀerences, with ∗p< 0.05 and ∗∗p< 0.05, respectively. Eﬀect sizes (ES)
were calculated using the equation r�Z/√N and were over time in each
group. SED, sedentary activity level; LIGHT, light activity level; MOD,
moderate activity level; VIG, vigorous activity level.
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exercise intervention went to sleep earlier, or were just less
active in the evenings to compensate for the increased ac-
tivity as a result of the intervention. +e eﬀect of this in-
creased daytime activity could therefore have a resulting
impact on sleep quantity and quality, reducing daytime
tiredness and potentially leading to beneﬁcial changes in
bothmotor and nonmotor symptoms [31]. Engagement with
cognitive and ﬁne motor skill tasks may reduce daytime
sleepiness and increase nighttime sleep and therefore the
active control group may have been receiving cognitive
stimulation which may have improved sleep time [32].
Interestingly, in the current study there was no impact
on fatigue as shown in previous research [33]. To date, there
is limited evidence to support the impact of exercise on
physical activity, fatigue, or sleep in PwP [20–23]. Variations
of resistance exercise training have been shown to speciﬁ-
cally improve subjective sleep quality whilst being safe and
feasible for PwP [34]. +e combination of aerobic and re-
sistance exercise interventions may be optimal for reducing
fatigue, increasing physical activity, and improving sleep
quality in PwP, as this was shown in healthy elderly people
who often experience disturbed sleep [35]. In addition, the
handwriting control group had engagement with cognitive
and ﬁne motor tasks which were also shown to improve
sleep. However, mechanisms underlying improved sleeping
habits diﬀer andmore robust research needs to be conducted
in PwP. Demographic data were collected pre- and post-
intervention, and although there were no signiﬁcant
changes, sleep problems and daytime sleepiness (as recorded
via the UPDRS subsections) tended to improve over the 6-
month period and should be evaluated in a full trial.
+ere were some limitations to the current study in that
the actual timings of sleep or sleep patterns were not
recorded throughout the study, with sleep times being es-
timated through increased sedentary behaviour. It would be
worth performing a subanalysis for those who experience
sleep issues or daytime sleepiness at baseline; however, if this
was performed in the current trial, the sample size would be
small and therefore the ﬁndings of limited relevance. Lack of
administration of more valid scales and tools (e.g., objective
assessment of sleep with polysomnography and Pittsburg
Sleep Quality Index) to assess sleep quality is an important
Table 3: Objective physical activity levels of participants following a 24-week exercise intervention averaged over two 12-hour periods.
Exercise Handwriting
Before After Z ES Before After Z ES
08.00–20.00
SED 0.65 0.63 −0.422 0.06 0.64 0.66 0.927 0.11
LIGHT 0.30 0.32 −0.638 0.08 0.31 0.27 −0.597 0.07
MOD 0.03 0.05 −0.919 0.12 0.03 0.02 −0.408 0.05
VIG 0 0 −0.118 0.02 0 0 −1.719 0.20
20.00–08.00
SED 0.75 0.87∗ −2.411 0.32 0.69 0.86∗ 3.236 0.38
LIGHT 0.22 0.12∗ −2.411 0.32 0.26 0.13∗ 3.111 0.37
MOD 0.01 0.01 −1.344 0.18 0.02 0.01∗ −2.662 0.31
VIG 0 0 −1.099 0.14 0 0 −1.112 0.13
+e exercise intervention consisted of both aerobic and anaerobic exercise training for 60minutes, twice a week for 24 weeks. Values aremedians of fraction of
time spent at each level of activity using an accelerometer. A Wilcoxon signed rank test was used to determine diﬀerences between pre- and postintervention
followed by a Mann–Whitney test for between-group diﬀerences, with ∗p< 0.05 and ∗∗p< 0.05, respectively. Eﬀect sizes (ES) were calculated using the
equation r�Z/√N. SED, sedentary activity level; LIGHT, light activity level; MOD, moderate activity level; VIG, vigorous activity level.
Table 4: Objective physical activity levels of participants following a 24-week exercise intervention averaged over one eight-hour overnight
and one four-hour periods.
Exercise Handwriting
Before After Z ES Before After Z ES
24.00–08.00
SED 0.76 0.89∗ −2.000 0.26 0.67 ∗0.89 2.906 0.34
LIGHT 0.20 0.09∗ −2.108 0.28 0.28 ∗0.09 −2.828 0.33
MOD 0.01 0 −1.658 0.22 0.01 ∗0 −2.080 0.25
VIG 0 0 −1.734 0.23 0 0 −1.821 0.21
20.00–24.00
SED 0.63 0.71∗ −2.389 0.31 0.68 ∗0.73 2.121 0.25
LIGHT 0.24 0.18∗ −2.433 0.32 0.21 0.14 −1.579 0.19
MOD 0 0.01 −1.622 0.21 0.01 0.01 −0.688 0.08
VIG 0 0 0 0 0 0 −0.307 0.04
+e exercise intervention consisted of both aerobic and anaerobic exercise training for 60minutes, twice a week for 24 weeks. Values aremedians of fraction of
time spent at each level of activity using an accelerometer. A Wilcoxon signed rank test was used to determine diﬀerences between pre- and postintervention
followed by a Mann–Whitney test for between-group diﬀerences, with ∗p< 0.05 and ∗∗p< 0.05, respectively. Eﬀect sizes (ES) were calculated using the
equation r�Z/√N. SED, sedentary activity level; LIGHT, light activity level; MOD, moderate activity level; VIG, vigorous activity level.
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limitation of this study. However, the results from this trial
add to the current evidence for exercise interventions as
a mean to improve symptom management and physical and
psychological functioning in PwP [3–8].
5. Conclusion
Evidence has shown that physical activity is beneﬁcial for
PwP, yet with little research showing its potential to improve
motor and nonmotor symptoms, quality of life, and sleep
patterns [36]. +e current study looked at the eﬀect of an
exercise intervention programme and an active handwriting
control group on general physical activity levels in PwP,
and it was found that participants experienced a signiﬁcant
increase in time spent sedentary overnight which may have
been linked to an improvement in sleep. Future studies
should explore the role of physical activity and behavioural
interventions to determine the eﬀect on nonmotor symp-
toms including sleep and fatigue in Parkinson’s.
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